Noelle‐Ann Sunstrom

University of Technology Sydney

Papers

1

Total Citations

34

H-Index

1

About

Noelle-Ann Sunstrom is a leading figure in bioprocessing and mammalian cell engineering, best known for revolutionizing the production of therapeutic proteins. Her seminal work introduced a high-throughput method for selecting recombinant Chinese hamster ovary (CHO) cells, a cornerstone of the biopharmaceutical industry. By engineering a dominant selectable and amplifiable metallothionein-GFP fusion protein, Sunstrom dramatically accelerated the traditionally laborious process of isolating high-producing clones. This innovation, detailed in her highly cited 2002 paper (34 citations), directly addressed a critical bottleneck in industrial cell line development, enabling faster and more efficient generation of cells for medical and industrial protein production. Her contributions have had a lasting impact on the efficiency of biomanufacturing, making her a key innovator in the field. Sunstrom’s work continues to influence researchers and engineers striving to optimize recombinant protein yields, solidifying her legacy as a pioneer in streamlining the path from gene to drug.

Research Focus

Key Achievements

1
H-Index
1
Papers
34
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
High‐throughput clonal selection of recombinant CHO cells using a dominant selectable and amplifiable metallothionein‐GFP fusion protein
34 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: University of Technology Sydney

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago